Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors

Citations Over TimeTop 10% of 2013 papers

Abstract

Natural products have long been recognized as a rich source of potent therapeutics but further development is often limited by high structural complexity and high molecular weight. In contrast, at the core of the thujaplicins is a lead-like tropolone scaffold characterized by relatively low molecular weight, ample sites for diversification, and metal-binding functionality poised for targeting a range of metalloenzyme drug targets. Here, we describe the development of this underutilized scaffold for the discovery of tropolone derivatives that function as isozyme-selective inhibitors of the validated anticancer drug target, histone deacetylase (HDAC). Several monosubstituted tropolones display remarkable levels of selectivity for HDAC2 and potently inhibit the growth of T-cell lymphocyte cell lines. The tropolones represent a new chemotype of isozyme-selective HDAC inhibitors.

Related Papers

• → cis-Dihydrocatechols as precursors to highly oxygenated troponoids: a fully regiocontrolled synthesis of 3,4-dimethoxy-α-tropolone(1992)16 cited
• → 273. The crystal structure of cupric tropolone and the dimensions of the tropolone ring(1951)27 cited
• → Studies on Tropolone Derivatives. III. On Methyl Ethers of Tropolone and Its Halogen Derivatives(1951)15 cited
• → Synthetic Studies on Colchicine-related Tropolones(1967)1 cited
• Synthesis of Acetyl Galactopyranosides Containing Tropolone Moiety(2004)